These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 16531505)

  • 1. Possible endogenous agonist mechanism for the activation of secretin family G protein-coupled receptors.
    Dong M; Pinon DI; Asmann YW; Miller LJ
    Mol Pharmacol; 2006 Jul; 70(1):206-13. PubMed ID: 16531505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor.
    Miller LJ; Dong M; Harikumar KG; Gao F
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):709-12. PubMed ID: 17635130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class B GPCRs: a hidden agonist within?
    Beinborn M
    Mol Pharmacol; 2006 Jul; 70(1):1-4. PubMed ID: 16632645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation.
    Park CG; Ganguli SC; Pinon DI; Hadac EM; Miller LJ
    J Pharmacol Exp Ther; 2000 Nov; 295(2):682-8. PubMed ID: 11046106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular approximations between residues 21 and 23 of secretin and its receptor: development of a model for peptide docking with the amino terminus of the secretin receptor.
    Dong M; Lam PC; Gao F; Hosohata K; Pinon DI; Sexton PM; Abagyan R; Miller LJ
    Mol Pharmacol; 2007 Aug; 72(2):280-90. PubMed ID: 17475809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular approximation between residue 10 of secretin and its receptor demonstrated by photoaffinity labeling.
    Dong M; Miller LJ
    Ann N Y Acad Sci; 2006 Jul; 1070():243-7. PubMed ID: 16888174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor.
    Ozcelebi F; Holtmann MH; Rentsch RU; Rao R; Miller LJ
    Mol Pharmacol; 1995 Nov; 48(5):818-24. PubMed ID: 7476911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of photoaffinity labeling to understand the molecular basis of ligand binding to the secretin receptor.
    Dong M; Miller LJ
    Ann N Y Acad Sci; 2006 Jul; 1070():248-64. PubMed ID: 16888175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
    Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.
    Harikumar KG; Morfis MM; Lisenbee CS; Sexton PM; Miller LJ
    Mol Pharmacol; 2006 Jan; 69(1):363-73. PubMed ID: 16244179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protean effects of a natural peptide agonist of the G protein-coupled secretin receptor demonstrated by receptor mutagenesis.
    Ganguli SC; Park CG; Holtmann MH; Hadac EM; Kenakin TP; Miller LJ
    J Pharmacol Exp Ther; 1998 Aug; 286(2):593-8. PubMed ID: 9694908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization and purification of the secretin receptor expressed in baculovirus-infected insect cells.
    Asmann YW; Dong M; Miller LJ
    Regul Pept; 2004 Dec; 123(1-3):217-23. PubMed ID: 15518915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells.
    Wang Y; Kong Y; Shei GJ; Kang L; Cvijic ME
    Assay Drug Dev Technol; 2011 Oct; 9(5):522-31. PubMed ID: 21561374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
    Dong M; Liu G; Pinon DI; Miller LJ
    Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
    Dong M; Lam PC; Pinon DI; Sexton PM; Abagyan R; Miller LJ
    Mol Pharmacol; 2008 Aug; 74(2):413-22. PubMed ID: 18467541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides.
    Dong M; Narang P; Pinon DI; Bordner AJ; Miller LJ
    Peptides; 2010 Jun; 31(6):1094-8. PubMed ID: 20214947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orthosteric agonist-binding pocket in the prototypic class B G-protein-coupled secretin receptor.
    Miller LJ; Dong M
    Biochem Soc Trans; 2013 Feb; 41(1):154-8. PubMed ID: 23356276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.